Conference Learning Objectives

Supplier Strategies Track

1. Explain how supply chain roles and responsibilities will differ because of the pandemic.
2. Compare methods to connect with your customers during the recovery period.
3. Outline key trends affecting healthcare in 2021 and beyond.
4. Outline strategies to meet the needs of providers and suppliers going forward.
5. Discuss new opportunities in the healthcare supply chain post- pandemic.
6. Define ways to collaborate to build stronger partnerships.
7. Define supply chain challenges IDNs continue to encounter as they shift from pandemic-mode to recovery-mode.
8. Describe key drivers influencing healthcare supply chain decision-makers.
9. Identify strategies providers and suppliers can forge stronger partnerships to reach desired outcomes.

 

Clinical Integration Track

1. Examine the critical success factors needed to accelerate the realization of a successful and sustainable clinical integration network in your organization.
2. Identify steps you can take to build a clinical integration strategy.
3. Discuss the influences at your organization and the impact they will have on implementing clinical integration strategies.
4. Outline the roles clinicians play in a successful healthcare supply chain.
5. Identify challenges of collaborating between supply chain and the clinical teams.
6. Formulate strategies to meet the challenges reducing organizational costs while improving the quality of care.
7. Identify the role of clinicians in managing and leveraging data. 
8. Describe the key performance metrics for clinicians to measure.
9. Outline actions needed to be taken to successfully construct data integration programs. 

 

Executive Management Track

1. Evaluate best practices for end-to-end assessment and monitoring.
2. Analyze methods and solutions to predict shortages and disruptions.
3. Identify ways supply chain leaders can optimize results and mitigate risks.
4. Compare agenda, both already enacted and proposed, of President Biden and previous policies of President Trump and impact on healthcare supply chain.
5. Identify positive changes and new administration will have on supply chain management and how to take advantage.
6. Analyze challenges that new administration’s policies will present and how to overcome.
7. Identify factors causing a shift in the US healthcare market post-COVID-19.
8. Analyze strategies that bring more value to customers who are fundamentally transforming.
9. Outline specific strategies to reorganize your team’s priorities and account plans to meet the changing needs of your customers.

 

Financial Operations Track

1. Identify negotiating tactics to improve communication and improve relationships with all stakeholders.
2. Define key strategies for successful contracting.
3. Describe “outside the box” strategies used during the pandemic and how they can be implemented in the future.
4. Analyze current data on mergers and acquisitions as well as at-risk hospitals.
5. Compare mergers and acquisitions in recent years and discover the strategies they used.
6. Identify opportunities and advantages of increased scales a broader footprint as IDNs add facilities.
7. Identify methods of how supply chain leaders engage internal and external stakeholders.
8. Evaluate chances for savings with both clinical and non-clinical expenditures.
9. Outline opportunities for improved product, service, and technology evidence-based decision making.

 

Pharmacy Track

1. Identify best practices for integrating virtual health services in your pharmacy department.
2. Outline federal laws and regulations that will affect your virtual health planning.
3. Evaluate financial implications on your pharmacy department and organization.
4. Identify the right Key Performance Indicators (KPIs) and various types of indicators.
5. Define a KPI driven culture and one that boosts data literacy across your organization.
6. Outline a process of KPI iteration and refining your KPIs on a schedule.
7. Outline biosimilars, their scientific background, and biologic cost trends. 
8. Explain the biosimilar manufacturing and approval process as well as barriers to market entry.
9. Evaluate biosimilars’ value proposition in value-based care.
10. Identify revenue opportunities for your pharmacy department.
11. Outline costs associated with changes and ways to offset.
12. Evaluate regulatory and compliance concerns that may impact your strategy.
13. Discuss the manufacturer’s claims and updates on pending litigation.
14. Identify any changes that could result from pending litigation and Biden administration.
15. Evaluate both short-term and long-term impacts on your organization.
16.  Identify payment rules that directly impact your pharmacy department.
17. Outline impact on organizational goals and bottom line.
18. Plan and discuss strategies that will optimize value and improve outcomes

 

Collaboration Track

1. Define goals for diversifying your supply chain and building a supplier diversity program.
2. Discuss ways to communicate to current and prospective partners and stakeholders to ensure their practices align with your IDN’s goals.
3. Identify opportunities to diversify other hospital contracts, such as those for advertising and marketing.
4.  Compare instances of success and lessons learned in healthcare from the COVID-19 pandemic.
5. Discuss strategies that will yield positive organizational results in 2021.
6.  Identify ways that change can optimize value and improve clinical outcomes.
7.  Identify strengths and vulnerabilities in local supply chains to improve future supply chain management.
8. Outline best practices in emergency management preparedness and response efforts for clinicians and supply chain leaders.
9. Explain ways to improve communication and information-sharing between all stakeholders, including clinicians, supply chain leaders, government agencies, and patients.

 

Senior Executives Forum (in-person conference only)

1. Outline current challenges facing senior executives.
2. Analyze recent successful initiatives and innovations in the healthcare industry.
3. Evaluate the future of the IDNs and the healthcare supply chain.
4. Identify the most common learnings from the COVID-19 pandemic.
5. Compare best practices for responding to these challenges.
6. Evaluate strategies to prepare for future disruptions.